Just a Little Girl and her Mommy…and Mommy’s Diabetes Accessories

Ruby's-AccessoriesLittle girls do love their accessories and mine has an eagle eye for detail.  Here, my daughter Ruby has on her cool Reef flip-flops, a white snap bracelet with cherries, blue mirror shades, a pink and green striped raccoon tail, and a multicolored hair wrap with hot pink feathers on the end.

Needless to say, when I changed up my diabetes supply cases this weekend, she was quick to notice.  “Mommy I like your new gold case with the white case better than the old silver case with the green case.  And I like the pink case too.”  Hmmm, that’s a lot of cases. She’s grown up knowing it’s “Mommy’s diabetes stuff” but we haven’t ever talked about which case is for what.

New-Diabetes-CasesMy husband and I explained that the white case was a “skin” case for Mommy’s OmniPod, the gold case was Mommy’s diabetes kit and the pink case was for Mommy’s CGM, which stands for Continuous Glucose Monitor.  “Rubes, do you know what continuous means?”

“No.”

“It means all the time and Glucose means sugar.  Do you know what monitor means?”

“No.”

“Monitor means watcher.  So, the pink case is Mommy’s all the time sugar watcher.”

Ruby grinned and chimed in with “And your bracelet is your sleep watcher!”

Oh, yeah, that’s right…there’s also the Fitbit Flex I wear, which tracks activity and sleep. Little girls…they don’t miss an “accessory” beat!

If you have to lift, try GlucoLift

GlucoliftairlinedrinkGlucoLift…sounds like some kind of super-fab brand name from the 1960s, right?  Maybe it was for a hair product to craft the perfect beehive “do”, or a popular baking yeast, or better yet some groovy, airline cocktail that you could only get on board an international Pan Am flight.  I mean…check out the cool, retro, rocket logo and the little stickers that add an “ed” on the end of the logo, thus proclaiming you “GlocoLifted.”

Glucolifted2

So, what is it really?  Glucose tabs, of course (this is a diabetes blog after all).  Besides the cool name and logo, why do I like them?  Do they taste good?  Well, um no….they’re glucose tabs.  But they do taste better than any other tabs I’ve had…and I’ve tried lots of tabs.   I’ve found some I can stomach and some that I’ve actually gone out of my way to return because they tasted so bad.  GlucoLift tabs also manage to be much less chalky than other brands.  Of course, to avoid the unpleasant chalky texture altogether you can get single-serve gels and liquids, which don’t taste half bad, but around here they’re 2-3$ a tube.   Treating a low with GlucoLift costs about 84 cents.  That’s a big difference when you might have 1 or 2 lows a day!   So “thanks” to all those companies out there making liquids and gels but I think I’ll save my “drinking” money for Starbucks and Guinness.

As for GlucoLift flavors, I use Orange Cream and Wildberry.  I leave the Orange Cream by the bed for night lows.  They aren’t terribly sweet or shockingly tart, so I like to think the mild flavor won’t wake me up as much.  To keep things interesting, I use mostly the Wildberry during the day, which taste a little stronger to me.  I haven’t tried the cherry flavor, as I have a general aversion to most things cherry-flavored.

I love that the company donates 1% of its profits to 1% for the Planet, especially since diabetes is associated with environmental risk factors.  I also appreciate that they only use natural dyes.  There has been an ongoing debate on adverse health affects of artificial dyes for years.  Should we trust the FDA to have our healthiest interest at heart or in the end is it all about the bottom dollar for the food industry giants?  For me, if I can use natural dye instead of artificial its one less adverse health unknown to deal with.  Don’t we already have enough health conditions to worry about?

GlocoLift logoOne small GlucoLift nitpic is that they don’t fit in tubes from other glucose tab manufacturers.  I like to refill and reuse these, so I can leave tubes of tabs in multiple bags, cars, etc.  They do fit in the GlucoLift tubes, which you can purchase separately, so no biggie in the end.  Bottom line:  Next time you need to restock on (blech) glucose tabs, remember it’s a bird, it’s a plane…no, it’s GlucoLift!


GlucoLIft Website

Forbes Magazine, “Living in Color: The Potential Dangers of Artificial Dyes.”

Is Type 1 Diabetes Different for Women than it is for Men?

I read this article that’s been circulating the Internet over the past few days entitled “Men With Type 1 Diabetes Are Better at Blood Sugar Control Than Women” and I found myself thinking that maybe this isn’t such a surprise.  Although the media’s inflammatory word choice for the article title seems to imply “men do it better”, the actual study title, “Sex differences in glycaemic control among people with type 1 diabetes” and study content lean towards biological differences.

Why am I so interested in this study?  As a woman I truly believe that hormone balance is a key issue in my BG control.  In fact I’m sure of it because I’ve tested my theories in my own private lab (i.e. my body).  When my hormones are balanced, I’m proactive with my BG control, fine-tuning my basal rates and having reasonably good predictability of bolus outcomes.  Whereas, when my hormones are not balanced, suddenly my fine-tuned basal rates and boluses don’t work as well as they used to, my insulin resistance goes up, and I’m constantly chasing highs and treating lows.  Even PWDs who don’t have extra complications beyond a normal monthly cycle often mention having higher BGs the week prior to their periods.  Are there type 1 diabetes issues related specifically to women that we should be aware of?

I decided to look further into it.  First, I wanted to actually see the real study this media story was based on.  It took some digging but I found the Abstract and Poster submitted by Dr. Wild to the European Association for the Study of Diabetes (EASD).  The study divided individuals into 3 age groups, under 15, 15-24, and over 24.  womens life stages 3The final conclusion states: “In this cross-sectional analysis of international data, there was a small difference in glycaemic control in males and females in the youngest age group, however control of type 1 diabetes was poorer in women than men in the two older strata.  This association did not appear to be confounded by age or duration of diabetes.”   Seems reasonable to me that the youngest strata is the least different from males, in that most of that age group hasn’t started a monthly cycle yet.  (Yes, I’m sure there are also many other biological reasons to consider.)

Secondly, I looked up information about Dr. Wild and found an interesting recent article she authored related to female cycles, diabetes, and diabetes-disease correlations, entitled “Diabetes in women − A life-course approach”.  I’m hoping this means more future studies will be conducted related to PWDs and hormones.  The lack of information on this has been frustrating for me, to say the least.  A few specific women’s health correlations to diabetes from the article are below.  While most of the correlations are negative, I’m certainly not trying to be Ms. Diabetes Doomsday.  But I do feel that as PWDs, these are women’s health correlations that we should be aware of.  If for no other reason, than that our local OBGYN, Endo, or Primary Physician may not be (mine weren’t aware of quite a few).

And after all, let’s call a spade a spade; women do tend to be more complicated ^_^

  • T1 diabetes appears to be associated with a delay in menarche and with menstrual irregularities.
  • Diabetes is associated with less frequent ovulation and the ability to conceive was about 75% of that of a non-diabetic.
  • There is evidence to suggest that women with diabetes undergo earlier menopause than women without diabetes.
  • Women lifecycles 2Effect of pregnancy on pre-existing diabetes:  Pregnancy leads to increased insulin resistance and is associated with a higher frequency of hypoglycaemic episodes (and reduced hypoglycaemia awareness) in women with type 1 diabetes.
  • If you have gestational diabetes, you are at increased risk for developing subsequent T2 diabetes.
  • Odds of developing T2 diabetes were 4-fold higher for women with PCOS than those without.
  • Post Menopausal Hormone Replacement Therapy (HRT) in PWDs:  Given the risks of both diabetes and the menopause, each case needs to be evaluated on its individual merits. Do the vasomotor and osteoporosis benefits outweigh the risks of endometrial or breast cancer? A large meta-analysis found that women with diabetes taking HRT had significantly reduced insulin resistance (12.9%, 95%CI 19.8–51.7%), reduced fasting glucose (11.5%, 95%CI 5.1–18.0%) and reduced fasting insulin (20.2%, 95%CI 4.2–36.3%), compared to those taking placebo or no treatment.
  • HRT in PWOD’s:  A meta-analysis of 107 randomized controlled trials found a 30% reduction in the incidence of diabetes in women taking HRT vs no treatment or placebo.  They also found non-diabetic users had significantly lower abdominal adiposity and waist circumference and more positive lipid profiles than non-users. Again individual women need to weigh the risks and benefits of HRT.
  • A number of studies have repeatedly confirmed osteoporosis as a complication of T1 diabetes.
  • Women with T1 diabetes were 12.25 times more likely to report an incident hip fracture than women without diabetes.
  • A number of researchers have looked at the relationship between diabetes and endometrial cancer and consistently found an increased risk of endometrial cancer amongst women with T2 diabetes.   No association has been shown for T1 diabetes.

You might also be interested in these related posts:

Synthetic Hormones and Type 1 Diabetes: A Call For Sharing Personal Stories

First Things First: Hormones and Insulin Requirements

My Fitbit Flex: A Delightful Surprise

Just got a new Fitbit Flex.  So far, I’ve only used it for two days, although two days was enough to have me feeling a bit like Wonder Woman with her indestructible wrist cuffs.

Fitbit_Wonder_Woman_cuffsWith logging diabetes data on my OmniPod, CGM, and BG tracking app, why on earth would I want yet another data entry device to worry about?!  Turns out one of the most attractive things about the Fitbit is that it isn’t subject to any of the proprietary B.S. that all my other devices fall victim to when it comes time to actually view the data.  It’s so simple to use that I can see my data with no more hassle than looking at a mobile app or website, it syncs automatically via WiFi, and works across all operating systems and platforms!  It’s open API and integrates with lots of mobile apps, giving it even more functionality.  Bonus: I don’t have to pierce my body to get it on, deal with calibrations, site changes, alarms, or discomfort.  I just wear it like a bracelet and essentially forget about it.  It’s providing me with a sense of freedom in patient generated data (PGD) that I’ve longed for with my diabetes devices.  Because it’s so much easier than what I’m used to, I’m actually motivated to set activity goals and complete them.  What a treat!

Fitbit_gollum_and_ringI know a lot of Fitbit users like to keep in touch via social media and share their data, but something else I really love about the Fitbit is that I don’t have to share.  This is my data and mine alone!  I’m not required to whip it out and share it with physicians at every turn in the road.  I don’t have to scramble to have all my data-entry ducks in a row, only to have my Endo pour over it (in 5 minutes flat!) offering the inevitable praise here and reprimand there.  It’s my Fitbit…my secret…my precious…


You might also like Big Diabetes Data Requires Big Analyses